For kvinder med en gestationsalder over 24 uger var der ikke forskel i dødeligheden (1, 7% i placebogruppen og 1, 5% i atosibangruppen).
For women with a gestational age greater than 24 weeks there was no difference in mortality rate (1.7% in the placebo group and 1.5% in the atosiban group).